Allogene Therapeutics, Inc. Purchase Commitment, Remaining Minimum Amount Committed
Allogene Therapeutics, Inc. (ALLO) had Purchase Commitment, Remaining Minimum Amount Committed of $2.30 million as of 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted · last filed 2024-11-07
- 2024-09-30: Purchase Commitment, Remaining Minimum Amount Committed $2.30M.
- 2024-06-30: Purchase Commitment, Remaining Minimum Amount Committed $700.00K.
- 2024-03-31: Purchase Commitment, Remaining Minimum Amount Committed $900.00K.
- 2023-12-31: Purchase Commitment, Remaining Minimum Amount Committed $2.10M.
| Period end | Purchase Commitment, Remaining Minimum Amount Committed |
|---|---|
| 2024-09-30 | $2.30M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $700.00K 10-Q · filed 2024-08-07 |
| 2024-03-31 | $900.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $2.10M 10-K · filed 2024-03-14 |
| 2023-09-30 | $4.00M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $400.00K 10-Q · filed 2023-08-02 |
| 2023-03-31 | $300.00K 10-Q · filed 2023-05-03 |
| 2022-12-31 | $300.00K 10-K/A · filed 2024-03-14 |
| 2022-09-30 | $400.00K 10-Q · filed 2022-11-02 |
| 2022-06-30 | $3.70M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $2.80M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $3.70M 10-K · filed 2022-02-23 |
| 2021-09-30 | $2.90M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $4.20M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $4.10M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $5.40M 10-K · filed 2021-02-25 |
| 2020-09-30 | $3.90M 10-Q · filed 2020-11-04 |
| 2020-06-30 | $5.60M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $5.30M 10-Q · filed 2020-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |